These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21355578)

  • 1. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA.
    Park S; Lippard SJ
    Biochemistry; 2011 Apr; 50(13):2567-74. PubMed ID: 21355578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature of full-length HMGB1 binding to cisplatin-modified DNA.
    Jung Y; Lippard SJ
    Biochemistry; 2003 Mar; 42(9):2664-71. PubMed ID: 12614161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-sensitive structural change in the A-domain of HMGB1 and its implication for the binding to cisplatin modified DNA.
    Wang J; Tochio N; Takeuchi A; Uewaki J; Kobayashi N; Tate S
    Biochem Biophys Res Commun; 2013 Nov; 441(4):701-6. PubMed ID: 24427810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein.
    Kasparkova J; Delalande O; Stros M; Elizondo-Riojas MA; Vojtiskova M; Kozelka J; Brabec V
    Biochemistry; 2003 Feb; 42(5):1234-44. PubMed ID: 12564926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding interaction of HMGB4 with cisplatin-modified DNA.
    Park S; Lippard SJ
    Biochemistry; 2012 Aug; 51(34):6728-37. PubMed ID: 22901013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
    Ohndorf UM; Whitehead JP; Raju NL; Lippard SJ
    Biochemistry; 1997 Dec; 36(48):14807-15. PubMed ID: 9398202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins.
    Wei M; Cohen SM; Silverman AP; Lippard SJ
    J Biol Chem; 2001 Oct; 276(42):38774-80. PubMed ID: 11514569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct.
    Chow CS; Barnes CM; Lippard SJ
    Biochemistry; 1995 Mar; 34(9):2956-64. PubMed ID: 7893709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser-induced photo-cross-linking of cisplatin-modified DNA to HMG-domain proteins.
    Mikata Y; He Q; Lippard SJ
    Biochemistry; 2001 Jun; 40(25):7533-41. PubMed ID: 11412107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two mutations of basic residues within the N-terminus of HMG-1 B domain with different effects on DNA supercoiling and binding to bent DNA.
    Stros M
    Biochemistry; 2001 Apr; 40(15):4769-79. PubMed ID: 11294645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
    Trimmer EE; Zamble DB; Lippard SJ; Essigmann JM
    Biochemistry; 1998 Jan; 37(1):352-62. PubMed ID: 9425057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
    Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ
    Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding to cisplatin-modified DNA by the Saccharomyces cerevisiae HMGB protein Nhp6A.
    Wong B; Masse JE; Yen YM; Giannikopoulos P; Feigon J; Johnson RC
    Biochemistry; 2002 Apr; 41(17):5404-14. PubMed ID: 11969400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stopped-flow fluorescence studies of HMG-domain protein binding to cisplatin-modified DNA.
    Jamieson ER; Lippard SJ
    Biochemistry; 2000 Jul; 39(29):8426-38. PubMed ID: 10913248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
    Novakova O; Kasparkova J; Malina J; Natile G; Brabec V
    Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of nuclear proteins that interact with platinum-modified DNA by photoaffinity labeling.
    Zhang CX; Chang PV; Lippard SJ
    J Am Chem Soc; 2004 Jun; 126(21):6536-7. PubMed ID: 15161265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding affinity of HMG1 protein to DNA modified by cis-platin and its analogs correlates with their antitumor activity.
    Pasheva EA; Ugrinova I; Spassovska NC; Pashev IG
    Int J Biochem Cell Biol; 2002 Jan; 34(1):87-92. PubMed ID: 11733188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
    Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
    Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts.
    Malina J; Kasparkova J; Natile G; Brabec V
    Chem Biol; 2002 May; 9(5):629-38. PubMed ID: 12031669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.
    Hofr C; Farrell N; Brabec V
    Nucleic Acids Res; 2001 May; 29(10):2034-40. PubMed ID: 11353072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.